Philippines Health Forum, Takeda, Better Health, Brighter Future
Takeda Healthcare Philippines,Inc.(THPI) a subsidiary of Takeda Pharmaceuticals Company,Ltd.(TPC) of Japan that imports Pharmaceuticals products in finished and semi finished form and a company that provides filipino patients with innovative medicines in gastroenterology,cardiology,oncology and womens health brings all physicians,the government ngo’s and healthcare industry together in a health forum to discuss the needs of Filipino Cancer patients and to address issues like access to innovative medicines.
The aim of this forum is to identify and develop solutions from the experts. Sustainable development goals for health and the status of cancer care in the Philippines. The forum also addresses Information and research, healthcare financing, role of the pharmaceutical industry related to access to innovative cancer medicine.
Ms. Leilani Eusebio – IcanServe Foundation
-13 years Cancer Survivor, wife, mom, patient advocate, executive Director of IcanServe Foundation
A testimonial from real life Cancer Patient Ms. Leilani Eusebio shares what challenges she went thru. She has done researches on her own, on going lab testings and financial challenges. She also took the time to ask one of the healthcare experts some personal issues that add an information not only for herself but to inform everyone how informative it is. During the presscon I ask her what drives her and motivates her to continue the advocacy in support for cancer patients. She was happy to answer she wanted to spread awareness of life saving medicines, even if their ability to pay is limited, there will always a healthcare workforce,Information, research, healthcare financing and existing commitment to enhance global health.
The goal is to improve health, responsive, financial risk protection and improved efficiency.
Press Conferrence Panelists:
Gabriel Georgy – President and General Manager, Takeda Healthcare Philippines Inc.
Dr. Sandra Torres – Medical Director, Takeda Healthcare Philippines Inc.
Isabel Torres – Global Head of Access to Medicines, Takeda Pharmaceuticals
Gordon Cameron – Vice President, Asia-Pacific, Takeda Pharmaceuticals
Dr. Robert Jackson – VP, global medicine head-CVM
Dr. Claire Soliman – past Vice President, Philippine Society of Media Oncology
Lani Eusebio – Executive Director, IcanServe Foundation Inc.
Takeda’s Access to Medicines Strategy:
Access to innovative medicines and quality healthcare is vital to the health of people across the world. Takeda’s new Access to medicines strategy will allow eligible patients in evolving healthcare systems to have access to their innovative and potencially life saving medicines, even if their ability to pay for full cost of treatment is limited.
This aligned to Takeda’s existing commitment to enhance global health. Takeda’s access to medicines strategy also goes beyond medicines by encompassing efforts in areas such as Research and Development, philanthrophy, donations and healthcare capacity building. Takeda aspires to achieve the greatest possible health impact for patients in a sustainable way parts of the world with high, unmet medical needs.